SG Americas Securities’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $643K | Sell |
32,806
-60,709
| -65% | -$1.49M | ﹤0.01% | 2035 |
|
|
2025
Q4 | $2.5M | Buy |
+93,515
| New | +$2.41M | ﹤0.01% | 1397 |
|
|
2025
Q3 | – | Sell |
-24,448
| Closed | -$561K | – | 3366 |
|
|
2025
Q2 | $561K | Buy |
+24,448
| New | +$607K | ﹤0.01% | 1588 |
|
|
2024
Q4 | – | Sell |
-35,234
| Closed | -$1.71M | – | 3117 |
|
|
2024
Q3 | $1.71M | Buy |
+35,234
| New | +$1.55M | 0.01% | 751 |
|
|
2024
Q1 | – | Sell |
-8,719
| Closed | -$539K | – | 2949 |
|
|
2023
Q4 | $539K | Sell |
8,719
-42,008
| -83% | -$2.21M | 0.01% | 1428 |
|
|
2023
Q3 | $2.33M | Buy |
+50,727
| New | +$2.77M | 0.03% | 630 |
|
|
2023
Q2 | – | Sell |
-16,870
| Closed | -$633K | – | 2261 |
|
|
2023
Q1 | $633K | Buy |
16,870
+6,282
| +59% | +$206K | 0.01% | 1529 |
|
|
2022
Q4 | $297K | Buy |
10,588
+6,154
| +139% | +$179K | ﹤0.01% | 1929 |
|
|
2022
Q3 | $125K | Sell |
4,434
-6,948
| -61% | -$227K | ﹤0.01% | 2681 |
|
|
2022
Q2 | $396K | Sell |
11,382
-19
| -0.2% | -$678 | ﹤0.01% | 2158 |
|
|
2022
Q1 | $409K | Sell |
11,401
-24,546
| -68% | -$696K | ﹤0.01% | 2006 |
|
|
2021
Q4 | $837K | Sell |
35,947
-43,656
| -55% | -$893K | ﹤0.01% | 1772 |
|
|
2021
Q3 | $1.51M | Buy |
+79,603
| New | +$1.56M | 0.01% | 1532 |
|
|
2021
Q2 | – | Sell |
-5,487
| Closed | -$101K | – | 2836 |
|
|
2021
Q1 | $101K | Buy |
+5,487
| New | +$102K | ﹤0.01% | 3080 |
|
|
2020
Q4 | – | Sell |
-83,818
| Closed | -$1.57M | – | 3318 |
|
|
2020
Q3 | $1.57M | Buy |
+83,818
| New | +$1.69M | 0.01% | 906 |
|
|
2020
Q2 | – | Sell |
-13,640
| Closed | -$202K | – | 3673 |
|
|
2020
Q1 | $202K | Buy |
13,640
+6,612
| +94% | +$115K | ﹤0.01% | 2495 |
|
|
2019
Q4 | $136K | Buy |
+7,028
| New | +$135K | ﹤0.01% | 2757 |
|
|
2019
Q2 | – | Sell |
-18,933
| Closed | -$387K | – | 3050 |
|
|
2019
Q1 | $387K | Buy |
18,933
+10,821
| +133% | +$242K | ﹤0.01% | 2057 |
|
|
2018
Q4 | $161K | Buy |
+8,112
| New | +$160K | ﹤0.01% | 2494 |
|
|
2018
Q3 | – | Sell |
-10,544
| Closed | -$161K | – | 3120 |
|
|
2018
Q2 | $161K | Buy |
+10,544
| New | +$184K | ﹤0.01% | 2747 |
|
|
2017
Q4 | – | Sell |
-16,385
| Closed | -$293K | – | 3166 |
|
|
2017
Q3 | $293K | Buy |
16,385
+10,195
| +165% | +$168K | ﹤0.01% | 2253 |
|
|
2017
Q2 | $111K | Buy |
+6,190
| New | +$98.2K | ﹤0.01% | 2840 |
|
|
2017
Q1 | – | Sell |
-23,102
| Closed | -$426K | – | 3258 |
|
|
2016
Q4 | $426K | Buy |
+23,102
| New | +$449K | ﹤0.01% | 1801 |
|
Other funds holding AMPH
VCM
BTW
SG Americas Securities's AMPH Position: Q1 2026 in Review
SG Americas Securities reduced its Amphastar Pharmaceuticals (AMPH) stake by 65% in Q1 2026, selling an estimated $1.49M and leaving 32,806 shares worth $643K. The position accounts for ﹤0.01% of the portfolio, ranked #2035.
SG Americas Securities first reported a position in AMPH in Q4 2016 and has held it in 23 quarters since. The position peaked at $2.5M in Q4 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- SG Americas Securities held 32,806 shares of Amphastar Pharmaceuticals worth $643K as of Q1 2026.
- SG Americas Securities sold 60,709 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $1.49M.
- Amphastar Pharmaceuticals made up ﹤0.01% of SG Americas Securities's portfolio in Q1 2026, its #2035 holding.
- SG Americas Securities first reported a position in Amphastar Pharmaceuticals in Q4 2016 and has held it in 23 quarters since.
- SG Americas Securities's Amphastar Pharmaceuticals position peaked at $2.5M in Q4 2025.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.